Mangalam Drugs (India) Technical Analysis
| MANGALAM | 99.69 3.45 3.34% |
As of the 27th of February, Mangalam Drugs secures the Mean Deviation of 1.8, insignificant risk adjusted performance, and Standard Deviation of 2.86. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mangalam Drugs And, as well as the relationship between them.
Mangalam Drugs Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mangalam, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MangalamMangalam |
Mangalam Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Mangalam Drugs And Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mangalam Drugs And volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Mangalam Drugs And Trend Analysis
Use this graph to draw trend lines for Mangalam Drugs And. You can use it to identify possible trend reversals for Mangalam Drugs as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Mangalam Drugs price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Mangalam Drugs Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Mangalam Drugs And applied against its price change over selected period. The best fit line has a slop of 0.29 , which may suggest that Mangalam Drugs And market price will keep on failing further. It has 122 observation points and a regression sum of squares at 3281.5, which is the sum of squared deviations for the predicted Mangalam Drugs price change compared to its average price change.About Mangalam Drugs Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mangalam Drugs And on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mangalam Drugs And based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mangalam Drugs And price pattern first instead of the macroeconomic environment surrounding Mangalam Drugs And. By analyzing Mangalam Drugs's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mangalam Drugs's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mangalam Drugs specific price patterns or momentum indicators. Please read more on our technical analysis page.
Mangalam Drugs February 27, 2025 Technical Indicators
Most technical analysis of Mangalam help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mangalam from various momentum indicators to cycle indicators. When you analyze Mangalam charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.10) | |||
| Mean Deviation | 1.8 | |||
| Coefficient Of Variation | (7,249) | |||
| Standard Deviation | 2.86 | |||
| Variance | 8.19 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 23.27 | |||
| Value At Risk | (3.43) | |||
| Potential Upside | 3.61 | |||
| Skewness | 1.54 | |||
| Kurtosis | 10.24 |
Complementary Tools for Mangalam Stock analysis
When running Mangalam Drugs' price analysis, check to measure Mangalam Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangalam Drugs is operating at the current time. Most of Mangalam Drugs' value examination focuses on studying past and present price action to predict the probability of Mangalam Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangalam Drugs' price. Additionally, you may evaluate how the addition of Mangalam Drugs to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |